SINGAPORE, Sept. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that it has received the "CDMO of the Year – Asia Pacific", "Best Biologics CDMO Award: Bioprocessing", and "Best...
Hence then, the article about wuxi biologics achieves cdmo of the year among three prestigious imapac awards was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi Biologics Achieves "CDMO of the Year" Among Three Prestigious IMAPAC Awards )
Also on site :